Myriad Genetics | MYGN - Operating Expenses


Myriad Genetics reported $212.8M in Operating Expenses for its fiscal quarter ending in December of 2025.





Operating Expenses Change Date
Agilent USD 1.44B 9M Mar/2026
Becton, Dickinson and Co. USD 24.13B 19.54B Mar/2026
Bio-Rad Laboratories USD 6.85B 6.21B Mar/2026
Bruker USD 813.2M 87.7M Mar/2026
Danaher USD 52.95B 47.61B Mar/2026
Illumina USD 852M 51M Mar/2026
J&J USD 17.44B 1.53B Mar/2026
Mettler Toledo International USD 713.2M 64.61M Mar/2026
Myriad Genetics USD 212.8M 16.2M Dec/2025
OraSure Technologies USD 40.35M 2.45M Dec/2025
Pacific Biosciences Of California USD 97.83M 41.29M Dec/2025
Quest Diagnostics USD 2.5B 76M Mar/2026
Quidel USD 1.85B 1.09B Mar/2026
Repligen USD 174.27M 3.67M Mar/2026
Revvity USD 628.34M 2.12M Mar/2026
Standard Biotools USD 45.72M 2.7M Dec/2025
Thermo Fisher Scientific USD 9.09B 821M Mar/2026
Veracyte USD 119.99M 3.99M Mar/2026
Waters USD 1.12B 457.15M Mar/2026